T1	intervention 47 64	physical activity
T3	intervention 77 102	simple lymphatic drainage
T2	condition 124 156	breast cancer-related lymphedema
T4	No-of-participants 408 410	52
T5	intervention-participants 487 489	25
T6	control 496 509	control group
T7	control-participants 515 517	27
T8	duration 681 690	six weeks
T9	outcome-Measure 771 807	circumference of the upper extremity
T10	outcome-Measure 809 825	symptom severity
T11	outcome-Measure 831 848	physical function
T12	outcome 883 912	upper extremity circumference
T13	outcome 1024 1066	Lymphedema-related symptom severity scores
